Newron Pharmaceuticals S.p.A.
NWRN
ISIN IT0004147952 / Valor 2791431
Newron Pharmaceuticals S.p.A.
UMushroom community rating:
About company
Newron Pharmaceuticals S.p.A., established in 1999 and headquartered in Bresso, Italy, with a subsidiary in Morristown, New Jersey, is a biopharmaceutical company specializing in the development of innovative therapies for central and peripheral nervous system disorders. The company aims to expand its product portfolio through both internal research and development and strategic licensing and acquisition of novel compounds targeting the central nervous system (CNS) at various stages of development. Newron's shares are publicly traded on the SIX Swiss Exchange under the ticker symbol NWRN, as well as on the primary market of the Düsseldorf Stock Exchange and XETRA under the trading symbol NP5.
Summarized from source with an LLMView SourceSector: HealthcareKey figures
Performance
Volatility
338 M
Market cap (USD)
187,807
Daily traded volume (Shares)
8.99 / 8.39
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
Uwe K.
Caterina F
Markus Fässler
EQUITIES OF THE SAME SECTOR
